| Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records T Nedelec, B Couvy-Duchesne, F Monnet, T Daly, M Ansart, L Gantzer, ... The Lancet Digital Health 4 (3), e169-e178, 2022 | 41 | 2022 |
| The ethics of innovation for Alzheimer’s disease: the risk of overstating evidence for metabolic enhancement protocols T Daly, I Mastroleo, D Gorski, S Epelbaum Theoretical Medicine and Bioethics 41 (5), 223-237, 2020 | 21 | 2020 |
| fMRI neurofeedback of higher visual areas and perceptual biases I Habes, S Rushton, SJ Johnston, MO Sokunbi, K Barawi, M Brosnan, ... Neuropsychologia 85, 208-215, 2016 | 20 | 2016 |
| Contribution of glycogen in supporting axon conduction in the peripheral and central nervous systems: the role of lactate TW Chambers, TP Daly, A Hockley, AM Brown Frontiers in neuroscience 8, 120249, 2014 | 17 | 2014 |
| Amyloid-β in Alzheimer’s disease: A study of citation practices of the amyloid cascade hypothesis between 1992 and 2019 T Daly, M Houot, A Barberousse, Y Agid, S Epelbaum Journal of Alzheimer's Disease 74 (4), 1309-1317, 2020 | 16 | 2020 |
| A proposal to make biomedical research into Alzheimer’s disease more democratic following an international survey with researchers T Daly, M Houot, A Barberousse, A Petit, S Epelbaum Journal of Alzheimer's Disease Reports 5 (1), 637-645, 2021 | 15 | 2021 |
| Finding the falsification threshold of the toxic proteinopathy hypothesis in neurodegeneration AJ Espay, K Herrup, T Daly Handbook of Clinical Neurology 192, 143-154, 2023 | 14 | 2023 |
| Avoiding over-reliance on multi-domain interventions for dementia prevention T Daly, I Mastroleo, R Migliaccio Journal of Alzheimer's Disease 90 (3), 989-992, 2022 | 12 | 2022 |
| An ethical argument for ending human trials of amyloid-lowering therapies in Alzheimer’s disease T Daly, K Herrup, AJ Espay AJOB neuroscience 15 (2), 80-81, 2024 | 11 | 2024 |
| An argument for simple tests of treatment of Alzheimer’s disease T Daly, I Mastroleo, V Henry, M Bourdenx Journal of Alzheimer's Disease 86 (1), 49-52, 2022 | 10 | 2022 |
| The letter as a forum to embed ethics into the scientific literature T Daly Accountability in Research, 1-2, 2023 | 9 | 2023 |
| Giving a fairer face to urban space: Progress on the long road to dementia prevention T Daly International Journal of Geriatric Psychiatry, 2021 | 9 | 2021 |
| Lecanemab: turning point, or status quo? An ethics perspective T Daly Brain 146 (9), e71-e72, 2023 | 8 | 2023 |
| Need for truthfulness in dementia research TP Daly bmj 380, 2023 | 8 | 2023 |
| From association to intervention: the Alzheimer’s Disease-Associated Processes and Targets (ADAPT) ontology T Daly, V Henry, M Bourdenx Journal of Alzheimer's Disease 94 (s1), S87-S96, 2023 | 8 | 2023 |
| Dementia prevention guidelines should explicitly mention deprivation T Daly AJOB neuroscience 15 (1), 73-76, 2024 | 7 | 2024 |
| The proteinopenia hypothesis: Loss of Aβ42 and the onset of Alzheimer’s Disease AJ Espay, K Herrup, KP Kepp, T Daly Ageing Research Reviews, 102112, 2023 | 7 | 2023 |
| The accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease T Daly, S Epelbaum AJOB Neuroscience, 2022 | 7 | 2022 |
| The diagnostic accuracy of AI-based predatory journal detectors: an analogy to diagnosis JA Teixeira da Silva, T Daly Diagnosis 10 (4), 446-447, 2023 | 6 | 2023 |
| Learning from the amyloid hypothesis: Adaptability, brevity, and clarity of ideas T Daly Neurological Sciences 44 (6), 2177-2178, 2023 | 6 | 2023 |
Stéphane EpelbaumInternational Leader Neuroscience - Eli Lilly在 lilly.com 的电子邮件经过验证
